Pulmonary physician and researcher, statements represent my personal views
Houston, TX
Joined December 2015
- Tweets24
- Following150
- Followers356
- Likes33
Congrats to an amazing team!
Our team at Baylor St. Luke's #lungtransplant program in 2023 was driven to provide early access, compassionate, and world-class care for advanced lung disease patients. @BCM_Surgery @BCM_ALD ♻️🫁
Ivan Rosas retweeted
The last 30 minutes of the second day of the virtual #PFStakeHolderSummit2022 still 107 (!) attendees - concluded with a superb discussion about better, faster clinical trial designs for #PulmonaryFibrosis. Cannot wait to see them start!!!
#CurePF
Read about New drug potentially identified to expand rheumatoid arthritis-associated interstitial lung disease treatment here: bcm.edu/news/new-drug-potent…
Ivan Rosas retweeted
A milestone for @BCM_Lung @BCM_ALD @BCMDeptMedicine! The #ILD clinic and #lungtransplant program has a new name, new meaning and a renewed mission-comprehensive patient care by a world class team! @ivanorosas @GarchaMed @GloriaWLiMD @GloorLoor @StLukesHealthTX @TXMedCenter
Ivan Rosas retweeted
Center for advanced #lung disease and lung transplantation has a new home! World class care for patients with #ild, advanced lung diseases and🫁 txp @BCMDeptMedicine @BCM_Lung @BCM_ALD @PFFORG @LungTXfndtn @GarchaMed @ivanorosas @GloorLoor @GloriaWLiMD @StLukesHealthTX
Ivan Rosas retweeted
A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease medrxiv.org/cgi/content/shor… #medRxiv
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. pubmed.ncbi.nlm.nih.gov/3481…
Read about Altered gene expression and cell interactions involved in COPD here: bcm.edu/news/altered-gene-ex…
Ivan Rosas retweeted
COPD Cell Atlas is finally out! Read “Characterization of the #COPD alveolar niche using single-cell RNA sequencing” for many exciting & novel insights!
Kudos @maorsauler @jmcdonou @ivanorosas, @ptimshel all others, for this amazing effort. See 🧵below
nature.com/articles/s41467-0… – at New Haven, CT
@jmcdonou and I are excited to share our findings in our manuscript "Characterization of the COPD alveolar niche using single-cell RNA sequencing" disq.us/t/44nd2rt, finally out @NatureComms. Follow the 🧵for more details.
Ivan Rosas retweeted
Tocilizumab + remdesivir vs remdesivir alone in severe #COVID19 pneumonia? NO benefit. Median time from randomization to 🏥 discharge or ready for discharge 14 days for both groups
💉REMDACTA RCT rdcu.be/cAROZ
💉Editorial rdcu.be/cAS30
Below visual abstract ⬇️
Ivan Rosas retweeted
Literature laureate Gabriel García Márquez’s international breakthrough came in 1967 with the novel 'Cien años de soledad' ('One Hundred Years of Solitude'). He is one of the foremost interpreters of magical realism in literature.
Learn more here: bit.ly/3fRg054
Ivan Rosas retweeted
REMDACTA Trial: Tocilizumab + remdesivir vs remdesivir alone in severe #COVID19 pneumonia? NO treatment benefit. Median time from randomization to 🏥 discharge or "ready for discharge" 14 days for both groups.
💉Results rdcu.be/cy6pU
💉Editorial bit.ly/2YBadvd
Ivan Rosas retweeted
Finally! Our Human Lung Endothelial Cell Atlas is out! Everything you wanted to know about lung endothelial cells - new insights, detailed descriptions & confirmations in mice & humans. Kudos @jonas_schupp @ivanorosas & team! #ScRNAseq #OpenAccess @yale ahajournals.org/doi/10.1161/…
Given the global impact of COVID-19 pneumonia on patients, we are disappointed that the REMDACTA study did not meet its endpoints businesswire.com/news/home/2…
Ivan Rosas retweeted
Very happy this is out! We identified new specific profibrotic macrophage markers and small molecules that reverted their gene expression. Always great to work with the #DreamTeam #IPFCellAtlas! Thanks all for your efforts and guidance!
Finally Out on @biorxivpreprint! Combination of #scRNAseq, #CyTOF & flow cytometry to study & target pro-fibrotic macrophages in pulmonary fibrosis is on #CurePF. Kudos Drs Rosas, Ayaub, Poli & the #IPFCellAtlas teams!! biorxiv.org/content/10.1101/…
Thx for questions and to our moderator and speakers!
An exciting start to the 2nd THORACon: Advanced Lung Disease Conference!
thoracon.org
@GloorLoor @DrRosengart @ivanorosas @BCM_ALD @LungAssociation @bcmhouston
@StLukesHealthTX #lungdisease #lungcancer #covid19 #THORACon
